Alaproclate
From Self-sufficiency
Jump to: navigation, search
| File:Alaproclate structure.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
1-(4-chlorophenyl)-2-methylpropan-2-yl 2-aminopropanoate | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number |
60719-82-6 60719-83-7 (hydrochloride) |
| ATC code | N06AB07 (WHO) |
| PubChem | CID 2081 |
| ChemSpider | 1997 |
| Chemical data | |
| Formula | C13H18ClNO2 |
| Molar mass | 255.740 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Alaproclate (GEA-654) is a psychoactive drug and research chemical derived from zimelidine (Normud, Zelmid) that was being developed as an antidepressant by the Swedish pharmaceutical company Astra AB (now AstraZeneca) in the 1970s. It acts as a selective serotonin reuptake inhibitor (SSRI), and along with zimelidine and indalpine, was one of the first of its kind. Development was discontinued due to the observation of liver complications in rodent studies.
See also
References
 | This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2007) |
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| GABAA PAMs |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| α2δ VDCC Blockers | |||||||||||
| 5-HT1A Agonists | |||||||||||
| H1 Antagonists | Diphenylmethanes: Captodiame • Hydroxyzine; Others: Brompheniramine • Chlorpheniramine • Pheniramine | ||||||||||
| CRH1 Antagonists | |||||||||||
| NK2 Antagonists | |||||||||||
| MCH1 antagonists | |||||||||||
| mGluR2/3 Agonists | |||||||||||
| mGluR5 NAMs | |||||||||||
| TSPO agonists | |||||||||||
| σ1 agonists | |||||||||||
| Others | Benzoctamine • Carbetocin • Demoxytocin • Mephenoxalone • Mepiprazole • Oxanamide • Oxytocin • Promoxolane • Tofisopam • Trimetozine • WAY-267,464 | ||||||||||
| |||||||||||
| |||||||||||||||
| |||||||||||||||
| |||||||||||||||
| |||||||||||||||
| |||||||||||||||
| |||||||||||||||
| |||||||||||||||
| 35px | This drug article relating to the nervous system is a stub. You can help ssf by expanding it. |
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Alaproclate&oldid=32341"
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Articles lacking sources from December 2007
- Articles with invalid date parameter in template
- All articles lacking sources
- Selective serotonin reuptake inhibitors
- Organochlorides
- Propionates
- Nervous system drug stubs
- 2Fix
